Among HER-2 expressing tumors, ERα and ERβ expression was observed in one and four patients each of FTC and PTC, respectively, and remaining all had exclusive HER-2 expression. This evidence concerns the gene ESR1 and thyroid cancer, nonmedullary, 2.